Russell Investments Group’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Russell Investments Group’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-9,086	Closed	-$545K	–	3389
2021 Q1	$545K	Buy	+9,086	New	+$329K	﹤0.01%	2494

Russell Investments Group's PAND Position: Q2 2021 in Review

Russell Investments Group sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 9,086 shares — an estimated $545K sold.

Russell Investments Group first reported a position in PAND in Q1 2021 and held it in 1 quarter. The position peaked at $545K in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

Russell Investments Group reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Russell Investments Group sold 9,086 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $545K.
Russell Investments Group first reported a position in Pandion Therapeutics Inc. Common Stock in Q1 2021 and held it in 1 quarter.
Russell Investments Group's Pandion Therapeutics Inc. Common Stock position peaked at $545K in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Russell Investments Group's 13F filing for Q2 2021, filed 4 Aug 2021.